TREATMENTS
Mole Diagnosis
Dr Shah can offer you a prompt diagnosis and treatment. He will explain your condition and offer a range of treatments options.
Mohs Micrographic Surgery
Dr Shah specialises in Mohs Surgery, a unique technique to accurately remove tumours with a 99% cure rate.
Skin Cancer
Dr Shah is an expert in skin cancer diagnosis and treatment. He will talk you through a range of treatments for your skin cancer.
General Dermatology
Dr Shah treats a wide range of conditions including acne, psoriasis, eczema, vitiligo and other rashes.
Vitilitgo & UV Photography
Dr Shah can discuss all treatment options for this difficult condition. Please note: he does not currently have access to an excimer laser.
Botox for Sweating
Dr Shah will offer you a prompt diagnosis and treatment. He will explain your condition and discuss a range of options in terms of treatment.
About Dr Dev Shah - Skin Doctor In Northwood And London
Dr Dev Shah is a UK-qualified Consultant Dermatologist and Skin Surgeon with over 25 years experience in general dermatology, skin cancer management, and Mohs micrographic surgery.
He treats a wide range of conditions including acne, eczema, psoriasis, vitiligo, suspicious moles, and skin cancers.
Dr Shah is known for his thoughtful, patient-centred approach and works collaboratively with patients to develop tailored treatment plans.
Please note that he does not see patients under the age of 12.
Experience
Dr Shah trained in Leicester with Professor Camp, followed by international experience in Australia, before completing his specialist dermatology and mohs surgery training in the award-winning department in Cardiff under Dr Richard Motley.
Dr Shah takes a holistic approach, focusing on the person as well as the skin condition. He recognises the psychological impact of skin disease, including stress and anxiety, and has undertaken further training in psychodermatology to support this aspect of care.
Dr Shah is actively involved in national dermatology leadership, including the British Association of Dermatology (BAD), vitiligo guideline working group and as an executive member of the British Society for Dermatological Surgery (BSDS). He is committed to patient-centred care and service development, ensuring patients remain at the heart of clinical practice.
Private Work
Dr Shah provides consultations, assessments, and treatments across several locations in Central and North West London. He manages a wide range of dermatological conditions, from common skin rashes to complex and advanced skin cancers.
Dr Shah established the first private Mohs surgery service at OneWelbeck (Central London) and OSD Healthcare (Hemel Hempstead) and currently chairs the Private CPS Skin Cancer MDT.
Dr Shah is committed to delivering high-quality, personalised care, offering tailored treatment plans designed around each patient’s individual needs and lifestyle. He consults from the following locations:
- Circle Health Group Bishopswood Hospital, Northwood, London HA6 2JW.
- Circle Health Group Chiltern, Great Missenden. HP16 0EN.
- One Stop Doctors, Hemel Hempstead. HP2 7YU.
- One Wellbeck, 1 Welbeck St, Marylebone, London W1G 0AR
NHS
Dr Shah is a Consultant Dermatologist and Cutaneous Surgeon at Amersham Hospital, Buckinghamshire Healthcare NHS Trust, where he holds a substantive post and is the Clinical lead and MDT Lead for Skin Surgery. He plays a key role within the department, supporting the delivery of high-quality, patient-focused dermatological care.
He initially established the Mohs surgery service at Hillingdon Hospital and works closely with colleagues across multiple specialties to ensure the best possible patient experience. He regularly manages patients with complex skin conditions and advanced skin cancers.
Prior to his current role, Dr Shah worked as a Consultant Mohs Surgeon at both Hillingdon NHS Foundation Trust and University College London Hospitals NHS Foundation Trust.
Research
Dr Shah’s research began with an interest in immune cells in eczema, reflecting his early focus on the immunological basis of skin disease.
He has since contributed to the development of the UK national vitiligo guidelines and continues to be involved in national guideline work.
He has also collaborated with Cardiff University on a pilot study exploring the use of microneedling in vitiligo. Although the study was affected by the COVID-19 pandemic and did not progress to completion, he remains interested in supporting further research in this area and encouraging international collaboration to develop the work further.









